Global Lincomycin Hydrochloride Market, 2020-2026

September 2020 | 100 pages | ID: G91EBD785ACEEN
Gen Consulting Company

Abstracts

Lincomycin is an antibiotic that is used both in human and animals. It inhibits bacteria by suppressing protein synthesis and growth. Lincomycin and its derivatives share a similar mechanism of action. A related compound, clindamycin, is derived from lincomycin by using thionyl chloride to replace the 7-hydroxy group with a chlorine atom with inversion of chirality. According to Gen Consulting Company, global lincomycin hydrochloride market is projected to grow at a CAGR of 4.22% during the forecast period 2020-2026. Growing potential for lincomycin hydrochloride in veterinary industry is the chief contributor for the growth of the market.

By application, the lincomycin hydrochloride market is classified into Veterinary, Human Use. On the basis of region, the lincomycin hydrochloride industry is analyzed across North America, Europe, Asia-Pacific, South America and MEA (the Middle East, and Africa).

By Application:

• Veterinary
• Human Use

By region, the market is analyzed across North America, Asia Pacific, Europe, Middle East & Africa and South America. This report forecasts revenue growth at global, regional & country level from 2020 to 2026.

• North America (U.S., Canada, Mexico, etc.)
• Asia-Pacific (China, Japan, India, Korea, Australia, Indonesia, Taiwan, Thailand, etc.)
• Europe (Germany, UK, France, Italy, Russia, Spain, etc.)
• Middle East & Africa (Turkey, Saudi Arabia, Iran, Egypt, Nigeria, UAE, Israel, South Africa, etc.)
• South America (Brazil, Argentina, Colombia, Chile, Venezuela, Peru, etc.)

The market research report covers the analysis of key stake holders of the lincomycin hydrochloride market. Some of the leading players profiled in the report include:

• Anhui Wanbei Pharmaceutical Co., Ltd.
• China Meheco Co., Ltd.
• Hangzhou Think Chemical Co., Ltd.
• Hengdian Group Holding Co., Ltd.
• Jiangxi Guoyao Pharmaceutical Limited Liability Company
• Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.
• NCPC Hualuan Pharmaceutical Co., Ltd.
• North China Pharmaceutical Group Corporation
• Suzhou no. 4 Pharmaceutical Factory Co., Ltd.
• Xinyu Pharmaceutical Co., Ltd.
• Yichang HEC Changjiang Pharmaceutical Co., Ltd.

*list is not exhaustive, request free sample to get a complete list of companies

The base year of the study is 2019, and forecasts run up to 2026.

Research Objective

• To analyze and forecast the market size of global lincomycin hydrochloride market.
• To classify and forecast global lincomycin hydrochloride market based on application.
• To identify drivers and challenges for global lincomycin hydrochloride market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in global lincomycin hydrochloride market.
• To conduct pricing analysis for global lincomycin hydrochloride market.
• To identify and analyze the profile of leading players operating in global lincomycin hydrochloride market.

The report is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities. Key target audience are:

• Manufacturers of lincomycin hydrochloride
• Raw material suppliers
• Market research and consulting firms
• Government bodies such as regulating authorities and policy makers
• Organizations, forums and alliances related to lincomycin hydrochloride

Contents

PART 1. INTRODUCTION

1.1 Market Definition
1.2 Key Benefit
1.3 Market Segment

PART 2. METHODOLOGY

2.1 Primary
2.2 Secondary

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

4.1 Introduction
4.2 Market Size and Forecast
4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
4.4 Impact of COVID-19 Pandemic on Global Economy
4.5 Porter's Five Forces Analysis
  4.5.1 Bargaining Power of Suppliers
  4.5.2 Bargaining Power of Consumers
  4.5.3 Threat of New Entrants
  4.5.4 Threat of Substitute Products and Services
  4.5.5 Degree of Competition

PART 7. GLOBAL MARKET FOR LINCOMYCIN HYDROCHLORIDE BY APPLICATION

7.1 Market Overview
7.2 Veterinary
  7.2.1 Market Size and Forecast
7.3 Human Use
  7.3.1 Market Size and Forecast

PART 8. GLOBAL MARKET FOR LINCOMYCIN HYDROCHLORIDE BY GEOGRAPHY

8.1 Overview
  8.1.1 Market Size and Forecast
8.2 North America
  8.2.1 Market Size and Forecast
  8.2.2 North America: Lincomycin Hydrochloride Market by Country
    8.2.2.1 United States
    8.2.2.2 Canada
    8.2.2.3 Mexico
8.3 Europe
  8.3.1 Market Size and Forecast
  8.3.2 Europe: Lincomycin Hydrochloride Market by Country
    8.3.2.1 Germany
    8.3.2.2 France
    8.3.2.3 United Kingdom
    8.3.2.4 Italy
    8.3.2.5 Rest of The Europe
8.4 Asia-Pacific
  8.4.1 Market Size and Forecast
  8.4.2 Asia-Pacific: Lincomycin Hydrochloride Market by Country
    8.4.2.1 China
    8.4.2.2 India
    8.4.2.3 Japan
    8.4.2.4 South Korea
    8.4.2.5 ASEAN Countries
8.5 Middle East and Africa (MEA)
  8.5.1 Market Size and Forecast
  8.5.2 MEA: Lincomycin Hydrochloride Market by Country
    8.5.2.1 Saudi Arabia
    8.5.2.2 South Africa
    8.5.2.3 Turkey
8.6 South America
  8.6.1 Market Size and Forecast
  8.6.2 South America: Lincomycin Hydrochloride Market by Country
    8.6.2.1 Brazil
    8.6.2.2 Argentina
    8.6.2.3 Rest of South America

PART 9. COMPETITIVE LANDSCAPE

9.1 Market Share
9.2 Mergers & Acquisitions, Agreements, Collaborations and Partnerships

PART 10. KEY COMPETITOR PROFILES

10.1 Anhui Wanbei Pharmaceutical Co., Ltd.
10.2 China Meheco Co., Ltd.
10.3 Hangzhou Think Chemical Co., Ltd.
10.4 Hengdian Group Holding Co., Ltd.
10.5 Jiangxi Guoyao Pharmaceutical Limited Liability Company
10.6 Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.
10.7 NCPC Hualuan Pharmaceutical Co., Ltd.
10.8 North China Pharmaceutical Group Corporation
10.9 Suzhou no. 4 Pharmaceutical Factory Co., Ltd.
10.10 Xinyu Pharmaceutical Co., Ltd.
10.11 Yichang HEC Changjiang Pharmaceutical Co., Ltd.
*LIST IS NOT EXHAUSTIVE

PART 11. PATENT ANALYSIS

11.1 Patent Statistics
11.2 Regional Analysis
11.3 Trends Analysis

DISCLAIMER

About

ABOUT GEN CONSULTING COMPANY